Parvovirus B19 in stem cell transplantation.

Intravenous immunoglobulin (IVIG) is the treatment of choice for B19V-induced pure red cell aplasia in immunocompromised hosts. Keywords: hematopoietic cell transplantation; immunocompromised; immunodeficiency; intravenous immunoglobulin; parvovirus B19 EN hematopoietic cell transplantation immunocompromised immunodeficiency intravenous immunoglobulin parvovirus B19 1 3 3 10/20/23 20231001 NES 231001 Abbreviations alloHCT allogeneic hematopoietic cell transplant B19V parvovirus B19 HIV human immunodeficiency virus IVIG intravenous immunoglobulin PCR polymerase chain reaction Parvovirus B19 (B19V) is a single-stranded DNA virus, which infects human erythroid progenitor cells. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus B19 infection: a retrospective study of 10 patients and review of the literature. [Extracted from the article]